» Articles » PMID: 26433952

Patient-relevant Needs and Treatment Goals in Nail Psoriasis

Overview
Journal Qual Life Res
Date 2015 Oct 5
PMID 26433952
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Patient-centered health care implies that medical decisions are made jointly by physician and patient, based on patient needs. Aims were to (a) identify treatment goals for a new questionnaire on patient needs and benefits in nail psoriasis treatment; (b) analyze the importance of treatment goals in patients with nail psoriasis in general and in defined subgroups; and (c) determine the association between overall treatment goal importance and quality of life.

Methods: The study comprised the following steps: qualitative survey on needs and burdens in 120 patients; development of items by an interdisciplinary expert group; item testing in 55 patients in four countries; revision of the questionnaire and assessment in 203 patients in six countries (Germany, Denmark, Italy, Spain, USA, Japan). The percentage of patients rating the goals as 'quite/very important' was compared between various patient subgroups.

Results: Based on 692 free-text statements, 26 items were developed which were reduced to 24 items after pilot testing. Each of these treatment goals applied to the majority of patients in the multi-center study. Goal importance increased with severity of nail psoriasis, but not with age or disease duration. Manual dexterity and social interaction were of particular importance. Goal importance and quality of life were associated, but not redundant (r = 0.612, p < 0.001).

Conclusions: Patients with nail psoriasis have manifold and specific treatment goals. Goal importance is a construct different from disease-specific quality of life and should be assessed separately. The new questionnaire can support goal setting in clinical practice.

Citing Articles

Development of a Specific Variant of Patient Benefit Index (PBI) Assessing Patient Needs, Goals and Benefits in Rosacea Treatment.

Augustin M, Sommer R, Blome C, Kirsten N, Langenbruch A Patient Prefer Adherence. 2023; 17:1335-1345.

PMID: 37284248 PMC: 10241185. DOI: 10.2147/PPA.S378724.


Patient-reported well-being in value-based care using tildrakizumab in a real-world setting: protocol of a multinational, phase IV, 1-cohort prospective observational study (the POSITIVE study).

Augustin M, Sommer R, Dauden E, Laws P, de Jong E, Fabbrocini G BMJ Open. 2023; 13(2):e060536.

PMID: 36792337 PMC: 9933754. DOI: 10.1136/bmjopen-2021-060536.


Assessment of body perception disturbances in complex regional pain syndrome: A systematic review using the COSMIN guideline.

Acapo S, Osinski T, Rulleau T, Dupeyron A, Nizard J Eur J Pain. 2022; 26(10):2060-2073.

PMID: 36065635 PMC: 9826130. DOI: 10.1002/ejp.2032.


Nail Psoriasis and Quality-of-Life Measurement in Clinical Trials: Call for the Use of Nail-Specific Instruments.

Blome C, Augustin M, Klein T Am J Clin Dermatol. 2021; 22(6):747-755.

PMID: 34383273 PMC: 8566428. DOI: 10.1007/s40257-021-00622-7.


Unmet Personal Patient Needs in Psoriasis Patients with Low Disease Activity on Adalimumab, Etanercept or Ustekinumab.

van Muijen M, Atalay S, van Vugt L, Vandermaesen L, van den Reek J, de Jong E Drugs Real World Outcomes. 2021; 8(2):163-172.

PMID: 33778926 PMC: 8128951. DOI: 10.1007/s40801-021-00227-w.


References
1.
de Korte J, Sprangers M, Mombers F, Bos J . Quality of life in patients with psoriasis: a systematic literature review. J Investig Dermatol Symp Proc. 2004; 9(2):140-7. DOI: 10.1046/j.1087-0024.2003.09110.x. View

2.
Bradley E, Bogardus Jr S, Tinetti M, Inouye S . Goal-setting in clinical medicine. Soc Sci Med. 1999; 49(2):267-78. DOI: 10.1016/s0277-9536(99)00107-0. View

3.
Baran R . The burden of nail psoriasis: an introduction. Dermatology. 2010; 221 Suppl 1:1-5. DOI: 10.1159/000316169. View

4.
Augustin M, Blome C, Rustenbach S, Reusch M, Radtke M . Routine skin cancer screening in Germany: First data on the impact on health care in dermatology. J Dtsch Dermatol Ges. 2010; 8(9):674-80. DOI: 10.1111/j.1610-0387.2010.07437.x. View

5.
Rich P, Scher R . Nail Psoriasis Severity Index: a useful tool for evaluation of nail psoriasis. J Am Acad Dermatol. 2003; 49(2):206-12. DOI: 10.1067/s0190-9622(03)00910-1. View